Kirn David Insider Trades & Stock Holdings

President and Chief Executive Officer · 4D Molecular Therapeutics, Inc. · Latest filing Oct 5, 2026

Kirn David, President and Chief Executive Officer at 4D Molecular Therapeutics, Inc. has 1 Form 4 trade on file since Oct 5, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($753.94K), net -$753.94K. Latest filing: disposed of 58.33K shares of $FDMT on Oct 5, 2026 at $12.92.

Trades on file

1

Open-market bought

$0

Open-market sold

$753.94K

Net open-market

-$753.94K

Latest filing

Oct 5, 2026

All insider trades by Kirn David

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 5, 2026	$FDMT	Sell (Open-market sale) 10b5-1	58.33K	$12.92	$753.94K			+0.6%			President and Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Kirn David traded

• $FDMT

Frequently asked questions

Has Kirn David been buying or selling stock?

Kirn David has 0 open-market purchases and 1 open-market sale on file, net -$753.94K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Kirn David's latest insider trade?

disposed of 58.33K shares of $FDMT on Oct 5, 2026 at $12.92.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.